Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro.
about
Selective incorporation of polyanionic molecules into hamster prions.Formation of native prions from minimal components in vitroClearance and prevention of prion infection in cell culture by anti-PrP antibodies.Induced prion protein controls immune-activated retroviruses in the mouse spleenThe intriguing prion disorders.Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins.Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion proteinHigh-resolution structure of infectious prion protein: the final frontierSearch for a prion-specific nucleic acid.Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties.Comparison of 2 synthetically generated recombinant prions.Involvement of endogenous retroviruses in prion diseases.Nucleic acid induced unfolding of recombinant prion protein globular fragment is pH dependent.Pathogenic chaperone-like RNA induces congophilic aggregates and facilitates neurodegeneration in DrosophilaPhosphorothioate oligonucleotides reduce PrP levels and prion infectivity in cultured cells.Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity.In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrateCross-talk between prion protein and quadruplex-forming nucleic acids: a dynamic complex formation.The reconstitution of mammalian prion infectivity de novo.Small-ruminant lentivirus enhances PrPSc accumulation in cultured sheep microglial cells.De novo generation of infectious prions with bacterially expressed recombinant prion protein.The peculiar interaction between mammalian prion protein and RNAThe role of RNA in mammalian prion protein conversion.Role of lipid in forming an infectious prion?Endogenous retrovirus-K and nervous system diseases.Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.Modulation of prion protein oligomerization, aggregation, and beta-sheet conversion by 4,4'-dianilino-1,1'-binaphthyl-5,5'-sulfonate (bis-ANS).Pathological implications of nucleic acid interactions with proteins associated with neurodegenerative diseasesPrion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cellsPhospholipid composition of membranes directs prions down alternative aggregation pathways.Genetic mapping of activity determinants within cellular prion proteins: N-terminal modules in PrPC offset pro-apoptotic activity of the Doppel helix B/B' region.Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease.Green fluorescent protein as a reporter of prion protein folding.Alpha2-macroglobulin is a potential facilitator of prion protein transformation.Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core.Ionic strength and transition metals control PrPSc protease resistance and conversion-inducing activity.A Sequence-Dependent DNA Condensation Induced by Prion Protein.A quantitative characterization of interaction between prion protein with nucleic acids.
P2860
Q24596538-03FC5B2F-B816-43B2-A5FA-344C7BB69017Q24676353-118AB282-6E95-4FAB-BF1E-09921F7487F5Q33248701-C1F2378E-6EAF-48A9-B8B4-AB694A9BE1ADQ33305220-5587CF97-89B8-4E82-8AB0-4B592E62D399Q33581653-CF862776-4A28-4A2F-8F16-CCEB296491FAQ33671560-48433922-3719-4749-B4BE-68FB98B25A39Q33680310-A0A003C5-45BF-49BB-9B86-5F8867F61294Q33725453-11533590-46F8-491F-A9D4-35BAFA558A77Q33911902-50477C67-72D7-485C-93F0-220EB8D36720Q34231846-B66F611D-8168-4094-B14C-8493B2939784Q34307252-301F8332-7267-4839-87D5-96E1431665BAQ34533430-FE986BB0-BACD-451E-9334-303CBFE6592CQ34621331-5D0BA5B8-6EA2-4D28-9B36-5E97566C1F6CQ35805255-AF97D141-5DF1-4FA7-BDDF-8F4F572F7186Q35844090-7A055F18-173D-443B-B9B2-30CC7F730907Q35968334-A54FB137-B4A9-4162-8986-04A3B5190720Q36147244-E8929BFF-7D2B-4F1C-8BA1-C737527E2A53Q36668697-036F153F-5E8C-42AE-9EDE-0CDACAA7671AQ36731455-31575FB4-C17E-43F3-916D-F381189545BEQ36933940-3F3D197C-F1CC-482D-8719-36CA596BB9D8Q37327452-944B46B0-BE62-4627-95D0-2E4B63A67745Q37355533-43F6B72C-58DC-42A6-8FA2-6E38C7391ED0Q37957794-07E16B1F-AC8C-430C-9228-88C789477D3DQ38098826-F0D51650-7A85-4EDB-9FAC-5C580E3EE069Q38241314-535770BC-9270-48EB-9A60-2D95BF4E259DQ38288126-B039A936-2CDD-4B23-812D-B22EEFE43702Q38347673-AC5A5DFD-FCEB-45A8-A739-01B1D7B9C7DAQ39310077-0442B721-69D4-434A-969B-848E97AFDB79Q39680285-3D087417-9BCF-4CE7-B568-36361EEB37EEQ40071117-29BE6FFF-734F-4F6C-AE5A-69978F4E9BECQ40508891-487A4F40-F0AF-40FF-8283-558F7AC0F93DQ43057853-18813293-FFD2-499B-ABD7-A3B1A9FF55B3Q43101604-9E79AE50-33C0-4941-A221-F562A0549FBAQ51798003-AA3E5068-EF6E-4A02-9F04-FA5079E8DB53Q51812016-B47B0484-0110-469E-A657-DEB43731F304Q51825374-803074F6-9A1E-4475-A8DC-794394266E5FQ52587085-57766BD5-2FCB-42CD-8096-8F737A129215Q55268338-A6ADDF95-C6C3-4868-AA9F-4FAA76770C30
P2860
Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Small, highly structured RNAs ...... PrP(Sen) to PrP(Res) in vitro.
@en
Small, highly structured RNAs ...... PrP(Sen) to PrP(Res) in vitro.
@nl
type
label
Small, highly structured RNAs ...... PrP(Sen) to PrP(Res) in vitro.
@en
Small, highly structured RNAs ...... PrP(Sen) to PrP(Res) in vitro.
@nl
prefLabel
Small, highly structured RNAs ...... PrP(Sen) to PrP(Res) in vitro.
@en
Small, highly structured RNAs ...... PrP(Sen) to PrP(Res) in vitro.
@nl
P2093
P1476
Small, highly structured RNAs ...... PrP(Sen) to PrP(Res) in vitro.
@en
P2093
Abraham Grossman
Brian Zeiler
Richard Rubenstein
Valentin Kryukov
Victor Adler
P356
10.1016/S0022-2836(03)00919-7
P407
P577
2003-09-01T00:00:00Z